GSK will pay the Chinese company $40 million upfront and up to $963 million in payments linked to development, regulatory, and commercial milestones.
What work are you leading at GSK as SVP and Global Head of Precision Medicine in R&D? Our purpose is to identify the right patient for the right medicine or vaccine at the right dose and the right ...
Multinational pharmaceutical company GSK’s commitment to invest up to $800 million in its facility near Marietta may have gone elsewhere without tax incentives approved by local officials last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results